Abstract
The options of surgical therapy for ulcerative colitis patients include total proctocolectomy and Brooke ileostomy, total proctocolectomy and the continent ileostomy, subtotal colectomy and ileorectal anastomosis, as well as the pelvic pouch procedure. A stoma is required for the first two mentioned procedures, and no stoma is required for subtotal colectomy and ileorectal anastomosis and the pelvic pouch procedure. In our experience, as well as others, there are very few candidates that are now acceptable for a colectomy and ileorectal anastomosis alone. All of the above procedures achieve continence except for the conventional ileostomy, but the reoperation rates for all of the procedures vary from 25–50% with the continent ileostomy to ~ 10–12% following the pelvic pouch procedure. With all types of surgeries there may be failures of therapy. As will be discussed below, the morbidity following a pelvic pouch procedure is considerable, and must be weighed against doing this procedure versus a total proctocolectomy and Brooke ileostomy. However, it must be stated that surgery is curative for ulcerative colitis, and ‘avoidance of colectomy’ should not be the major outcome measure when one is assessing a patient for either medical or surgery therapy. The disease is completely removed with any form of total proctocolectomy and in most cases with the pelvic pouch procedure, although recently the transitional zone as well as 1–2 cm of anal mucosa may be left behind using a stapled technique for the pelvic pouch procedure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Stern H, Walfisch S, Mullen B, McLeod RS, Cohen Z. Cancer in an ileo-anal reservoir–a new late complication. Gut. 1990; 3: 473–5.
Fleshman JW, Cohen Z, McLeod RS, Stern H, Blair J. The ileal reservoir and ileo-anal anastomosis procedure–factors affecting technical and functional outcome. Dis Colon Rectum. 1989; 31: 10–16.
McIntyre TB, Pemberton J, Wolff B, Beart R, Dozois R. Comparing functional results one year and ten years after ileal pouch anal anastomosis for chronic ulcerative colitis. Dis Colon Rectum. 1994; 37: 303–7.
McLeod RS, Churchill N, Lock A, Vandenburg H, Cohen Z. Assessment of quality of life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology. 1991; 101: 1307–13.
Cohen Z. Ileo-anal pouches–is mucosectomy necessary? Can J Gastroenterol. 1993; 7: 1–3.
Lofberg R, Liljeqvust L, Lindquist K, Veress B, Reinholt GP, Tribukait B. Dysplasia and DNA aneuploidy in a pelvic pouch. Dis Colon Rectum. 1991; 34: 280–4.
Cohen Z, Steven W, O’Connor B, Stern H, McLeod RS. Continuing evolution of the pelvic pouch procedure. Surgery. 1992; 216: 506–12.
Archambault A, Feagan B, Fedorak R et al. The Canadian Crohn’s Disease Relapse Prevention Trial (CCRPT). Gastroenterology. 1992; 102: A591.
Lichtiger S. Cyclosporine therapy in inflammatory bowel disease–open-label experience. Mount Sinai J Med. 1990; 57: 315–19.
Lichtiger S, Present DH. Preliminary report: cyclosporine in treatment of severe active ulcerative colitis. Lancet. 1990; 336: 16–19.
Leddin DJ, Vanzanten V, Sidorov JJ, Stewart J, Tripathi D, Williams CD. Colectomy following treatment of Crohn’s colitis with cyclosporin. Post presentation. Trends in Inflammatory Bowel Disease Therapy. Victoria, British Columbia, April 1994.
Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med. 1989; 110: 353–6.
Kozarek RA, Patterson DJ, Gelfand MD, Ball TJ, Botomon VA. Long-term use of methotrexate in inflammatory bowel disease: severe disease 3, Drug Therapy 2. Seventh inning stretch. Gastroenterology. 1992; 102: A648 (abstr.).
Arora S, Katkov WN, Cooley J et al. A double blind, randomized, placebo-controlled trial of methotrexate in Crohn’s disease. Gastroenterology. 1993; 102: A647.
Lichtiger S, Present DH, Kornbluth A, Hanauer S. Cyclosporin A in the treatment of severe, refractory ulcerative colitis: a double blinded placebo controlled trial. Gastroenterology. 1993; 102 (4): A732.
Archambault A, Feagan B, Fedorak R et al. The Canadian Crohn’s Relapse Prevention Trial. Gastroenterology. 1992; 4: A591.
Corman E, Reinus JF. Cyclosporine use in steroid-resistant Crohn’s disease–grasping at new straws? Am J Gastroenterol. 1990; 85: 758–9.
Pemberton JH, Kelly KA, Beart RW, Dozois R, Wolff B, Ilstrup DM. Ileal pouch anal anastomosis for chronic ulcerative colitis–long term results. Ann Surg. 1987; 206: 504–13.
Salemans JM, Nagengast M, Lubbers EJ, Kuijpers JH. Postoperative and long-term results of ileal pouch anal anastomosis for ulcerative colitis in familial polyposis. Dig Dis Sci. 1992; 37: 1882–9.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Kluwer Academic Publishers and Axcan Pharma, Inc.
About this chapter
Cite this chapter
Cohen, Z. (1994). Therapy of IBD in 1994: a surgeon’s perspective. In: Sutherland, L.R., et al. Inflammatory Bowel Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0371-5_42
Download citation
DOI: https://doi.org/10.1007/978-94-009-0371-5_42
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6653-2
Online ISBN: 978-94-009-0371-5
eBook Packages: Springer Book Archive